And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck (MRK) over the intellectual property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. Gabelli’s Jing He stands by her contention that Gilead is “the most undervalued stock” in biotech:
Gilead Sciences CEO John Milligan Victor J. Blue/Bloomberg News
Boston, MA, based Investment company Adage Capital Partners Gp Llc buys Wells Fargo, General Dynamics, Puma Biotechnology, Johnson Controls International PLC, NextEra Energy, Walt Disney Co, The Mosaic Co, PerkinElmer, Goldman Sachs Group, NXP Semiconductors NV, sells Puma Biotechnology, LinkedIn, Sempra Energy, Allergan PLC, Honeywell International during the 3-months ended 2016-12-31, according....More>>>
The Republican win is an unexpected event that will ironically add to an already long list of headwinds Valeant Pharmaceuticals (NYSE:VRX) faces. Markets are now pricing in interest rate risks in the entire biotechnology sector. As interest on debt costs go up, biotech stocks in the early innings of drug development will have less money available for funding their clinical studies. Markets reacted....More>>>
Poor Caterpillar (CAT). Everything had been looking up for the company, and then suddenly it wasn’t. Does that make it a perfect time for an upgrade?
Agence France-Presse/Getty Images
Caterpillar had rebounded with the global economy and as part of the Trump trade, helping to push its shares up 25% over the past 12 months. Its shares, however, have dropped 5.3% during the past....More>>>
Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:
ImmunoGen (NASDAQ:IMGN) is a clinical stage biotech company that is focused on cancer therapeutics. It has developed an antibody-drug conjugate or “ADC” technology which is already being used in an approved and marketed product and is also being developed for use in a few other clinical stage candidates that are part of ImmunoGen’s current pipeline. The lead pipeline candidate....More>>>
Stocks edged higher today despite Donald Trump trashing the health care sector in his press conference today.
The S&P 500 rose 0.3% to 2,275.32 today, while the Dow Jones Industrial Average gained 98.75 points, or 0.5%, to 19,954.28. The Nasdaq Composite advanced 0.2% to5,563.65–and hit its fifth consecutive high–despite the fact that biotech stocks tumbled....More>>>
Related MRK Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim The Stocks That Moved The S&P, Dow And Nasdaq Today The Vetr community has upgraded $MRK to 3.5-Stars. (Vetr) Related ONVO Add 3D Printing To Your Portfolio With These Stocks Organovo Holdings Sees FY 2016....More>>>
This autumn Apple (NASDAQ:AAPL) will release a new iPhone design, and the fact that it postponed a new design and kept the 6 design for three years instead of two suggests it has something that will attract attention. However, it will really still “just” be another iPhone. Meanwhile, we have some indications that Apple is working on AR glasses (of which more later) and certainly was....More>>>
Every day Florida's population swells by more than 1,000 people, many of them retirees relocating for the second halves of their lives. There's little mystery why: Even in the coldest months of the year, the average daily high is at least 70 degrees, and the temperature rarely dips below 50 in th